Additionally, 12.5% of nasopharyngeal carcinoma (NPC) cell lines exhibit RASSF4 deletion, with highly methylated promoter regions, and demethylating agents can restore its mRNA expression [15,43,48]. Here, RASSF4 is linked to nasopharyngeal carcinoma.